papers, finally extracting a binder with his research. Everything was computerized, saved to CD and DVD, stored in his secure lab and also off-site at a bank vault, but he also printed his data. Some might find his aversion to trusting technology like computers antithetic to his high-tech research, but he also knew the exact failure rates of microprocessors and the surges of the power grid in Sachsen-Anhalt that had fried far too many computers, even those supposedly protected by surge protectors and power back-up systems.
Altenstein turned to midway in his binder, his eyes shifting from the pages to Conradâs waiting glare. âAs I told you before, we can target specific genes or other DNA factors with the nanoinhibitors.â He paused and tried to find the words that would not confuse Conrad. He knew that Conrad was a businessman, not a scientist. He had people in his company for that. He was a genius taking technological innovations and exploiting them for commercial use, though. Altensteinâs research would be no different.
âPlease continue, Herr Professor.â
âRight. So, we had mice with a bacterial infection, for instance, that we then injected with the inhibitors designed to attack bacteria.â Altenstein smiled broadly now, his eyes moving from the papers in the binder to Conrad. âThe nanos wiped out the bacteria within twenty-four hours.â
âMy God.â
Altenstein felt almost like God at that moment. âAbsolutely. We have replicated the studies with more than five of the most common bacteria. Same result.â
âThis will make antibiotics obsolete,â Conrad said, his eyes sparkling with the possibilities. He was seeing Euro signs now.
âThe other genetic factors you asked to study seem equally promising,â Altenstein said, flipping through more pages. He didnât have to rely on paper; he knew exactly off the top of his mind the results of his work. âWe tested for a genetic defect in several miceâthose with a predisposition to hormonal obesityâand all mice injected with the nanoinhibitor programmed to eliminate this hormone did just that. All mice lost weight.â
âMy God.â Conrad shook his head. âWill this work with any gene?â
Altenstein hesitated, wondering why he would ask this question. âI would think so. With proper inhibitors.â
Conrad was thinking hard now, his head moving up and down. âCould you reverse the problem?â
âWhat do you mean?â
âInstead of inhibiting a process. . .could you make the nanos react to a genetic factor?â
âYou mean attack a certain genetic trait?â Altenstein shrugged. âItâs possible.â After he said it, he regretted having done so. A light went off in the professorâs brain. God indeed.
âHow long before you could test for that?â Conrad said, his voice shifting from jazz to heavy metal.
âI would have to get mice with a particular trait we wanted to eliminate,â Altenstein said. âThat could take a while.â
âLetâs not reinvent the wheel here, professor.â Conrad rubbed his chin. âWhatâs the most obvious genetic trait?â
Altenstein didnât want to answer. He couldnât.
âWhat about hair color?â Conrad said. âYou have white mice. . .and black mice. Iâve seen them in your lab.â
âYou want me to test mice with white or black fur?â
âCan you do that?â
Altenstein wanted to say no, but he was sure Conrad could ask a scientist on his staff who would tell him the truth. He probably already had, he guessed. With the entire mouse genome in the university database, fur color would be the easiest factor to test.
âSure.â Altenstein said tentatively.
âWonderful. Do that as soon as possible.â
âBut your company could make a fortune from the antibiotic inhibitor alone, not to mention the